GA HR1524

Urges the Georgia General Assembly to reschedule marijuana from a Schedule I to a Schedule III substance under state law, aligning with presidential Executive Order 14370 issued December 18, 2025

Cites 2023 FDA findings supporting medical marijuana use for treating anorexia, nausea and vomiting, and pain, with over 30,000 licensed healthcare practitioners across 43 jurisdictions authorized to recommend it for more than 6 million registered patients

Notes that approximately 40 states plus the District of Columbia have regulated medical marijuana programs, and chronic pain affects nearly 1 in 4 adults and more than 1 in 3 seniors nationwide

References the Department of Justice's May 2024 proposed rule to reschedule marijuana to Schedule III, which received nearly 43,000 public comments and awaits an administrative law hearing

Calls for increased medical marijuana and cannabidiol research to better inform patients and doctors in the United States and Georgia